VANI
What one share of Vivani Medical holds
Electromedical and Electrotherapeutic Apparatus
Vivani Medical, Inc. (“Vivani,” the “Company,” “we,” “us,” “our” or similar terms) is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal™ technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases.
Vivani Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.35 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$0.35 |
| Cash and investments | $0.22 |
| Book value | $0.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.81 | −$6.71 | $0.10 | −$5.17 | — | — |
| 2017 | $1.18 | −$4.21 | $0.04 | −$3.58 | — | — |
| 2018 | $0.83 | −$4.23 | $0.02 | −$3.61 | — | — |
| 2019 | $0.23 | −$2.28 | $0.03 | −$1.91 | — | — |
| 2020 | — | −$0.72 | $0.02 | −$0.83 | — | — |
| 2023 | — | −$0.50 | $0.02 | −$0.48 | — | $0.41 |
| 2024 | $0.00 | −$0.43 | $0.01 | −$0.39 | — | $0.30 |
| 2025 | $0.00 | −$0.43 | $0.02 | −$0.41 | — | $0.21 |